点击显示 收起
【关键词】 glucose
Conjoint Renal Laboratory, Queensland Health Pathology Service, Royal Brisbane and Women's Hospital, Bancroft Centre, Brisbane
Department of Molecular Cellular Pathology, School of Medicine, University of Queensland, Herston, Brisbane
Department of Renal Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia
ABSTRACT
In vitro models of diabetic nephropathy that assess the role of hyperglycemia on proximal tubular cell turnover commonly compare cells in a high-glucose medium (25 or 30 mM) with a low-glucose medium (5 to 6.1 mM). Any cellular growth changes observed are usually attributed to the effect of high glucose. We hypothesize that in such experiments, glucose concentrations in the low-glucose medium may decline during the course of the experiments to levels that inhibit cell growth leading to the comparative conclusion that high glucose induces hyperplasia and/or hypertrophy. In this study, primary cultures of human proximal tubular epithelial cells (PTEC) and immortalized HK-2 cells were exposed to low (5 mM) or high (17, 30, or 47 mM) glucose for up to 6 days (PTEC) and 48 h (HK-2). When culture media were not replenished, low glucose induced a significant increase in necrosis and release of lactate dehydrogenase and a decrease in proliferation, metabolic activity, and protein content without any changes in apoptosis. High-glucose media failed to induce any of these changes. Glucose was undetectable in the low-glucose culture medium after 72 h. No significant differences were observed between any of the treatment groups when culture media were replenished daily. We conclude that regular replenishment of culture media is necessary to prevent the emergence of artifactual and misleading differences between high- and low-glucose groups. The current knowledge of the pathophysiology of high glucose based on cell culture systems may need to be reevaluated.
apoptosis; diabetic nephropathy; hyperglycemia; necrosis; proximal tubule
DIABETES IS THE LEADING CAUSE of end-stage renal disease in the Western world (18). Apart from genetic susceptibility and obesity, chronic exposure of renal tissue to elevated blood glucose levels has been suggested to be an essential factor in the development of overt diabetic nephropathy (DN) (25, 26). DN is primarily a disease of the glomerulus. The thickening of the glomerular basement membrane and the expansion of extracellular matrix significantly reduce the surface area available for filtration and gradually occlude the capillary lumen. This leads to hyperfiltration of residual filtration surfaces and eventually microalbuminuria (13). However, nephromegaly in the early stages of diabetes and the correlation of tubulointerstitial pathology rather than glomerular pathology with declining renal function in DN (2, 3, 24, 29) suggest the involvement of the tubulointerstitium. Although the etiology of the tubulointerstitial pathology in DN is not fully understood, much attention has focused on the role of high glucose per se. It is now accepted that tubular cells are a primary target of hyperglycemia and that chronic exposure to elevated blood glucose levels contributes to the tubulointerstitial changes seen in overt DN (3, 25, 26).
Much of the information on a direct role of high glucose on the tubulointerstitium is derived from in vitro studies. Proximal tubular epithelial cells (PTEC) exposed to high-glucose concentrations (25 to 30 mM) are reported to undergo hypertrophy (16, 30) or hyperplasia (10, 11). It has been suggested that such increases in cell growth correspond with the tubulointerstitial hyperplasia and hypertrophy observed in animal models shortly after the onset of diabetes (10, 11, 22). In contrast, other studies (1, 15, 27, 28) show that exposure of PTEC to high glucose (25 to 30 mM) induces cell death by apoptosis, offering a possible explanation of the mechanism for tubular atrophy observed in advanced stages of DN.
In vitro models of DN using PTEC traditionally compare cells in a low-glucose medium (5 to 6.1 mM) with cells in a high-glucose medium (25 or 30 mM). Any observed changes in growth characteristics are then attributed to the effect of the high-glucose medium on the cells under investigation. However, it is well known that most cells require glucose-enriched media to survive in vitro (10 to 25 mM; 17 mM for PTEC). Thus experiments that consider a glucose concentration of 5 to 6.1 mM to be normoglycemic (the normal range for glucose is 3.0 to 7.8 mM) may in fact be "low" for these cells and a glucose concentration considered to be high (25 to 30 mM) may be not much higher than their "optimum" glucose concentration in vitro. Therefore, experimental models that use a medium with low-glucose concentrations as controls and then compare the growth effects of PTEC with a medium containing high-glucose concentrations may be fundamentally flawed.
We hypothesize that glucose concentrations in the low-glucose medium (5 to 6.1 mM) may decline with the passage of time and reach levels that do not support growth and possibly induce cell death. High-glucose media on the other hand (25 to 30 mM) may still have glucose levels capable of sustaining growth despite substantial reductions in glucose concentrations with time. Regular replenishment of culture medium may overcome the potential problem of glucose depletion with the result that differences in cell growth or death between cells exposed to low- and high-glucose concentrations are not observed. Based on these hypotheses, we reevaluated the role of high glucose on cell death (apoptosis and necrosis) and cell growth (proliferation) of primary cultures of human PTEC and HK-2 cells, an immortalized human PTEC line.
MATERIALS AND METHODS
The use of human PTEC in this study was approved by the Human Research Ethics Committee of the Royal Brisbane and Women's Hospital, Brisbane, Australia. Written informed consent was obtained from patients before nephrectomy for the collection of cortical tissue samples.
Chemicals. Chemicals for cell culture were obtained either from Sigma (Castle Hill, NSW, Australia), GIBCO (Invitrogen, Carlsbad, CA), or Roche (Roche Diagnostics) unless stated otherwise.
Isolation and culture of human PTEC. PTEC were isolated and cultured following the method of Glynne (4). Renal cortical tissues from the normal region of nephrectomy samples were collected in precooled (4°C) Hanks’ balanced salt solution (HBSS) containing penicillin (50 U/ml), streptomycin (50 μg/ml), and amphoterecin B (0.125 μg/ml). After the capsule was removed, the extreme cortex was cut into small pieces and centrifuged at 200 g for 5 min at 4°C. The supernatant was discarded and the tissue fragments were suspended in 1 mg/ml (in HBSS) of type II collagenase (Worthington Biochemical) and incubated for 1 h at 37°C. The digest was passed through a 100-μm sieve followed by a 40-μm sieve (Beckton Dickinson). The sieved cells were centrifuged (200 g, 5 min, 4°C) and seeded into 75-cm2 tissue-culture flasks that had been coated with collagen S and FBS. The cells were grown in serum-free medium which was DMEM and Ham's F12 (DMEM/F-12; glucose concentration, 17 mM) containing 15 mM HEPES buffer, L-glutamine, and pyridoxine hydrochloride. The medium was supplemented with epidermal growth factor (10 ng/ml), insulin (10 μg/ml), transferrin (5 μg/ml), selenium (5 ng/ml), hydrocortisone (36 ng/ml), triiodothyronin (4 pg/ml), penicillin (50 U/ml), streptomycin (50 μg/ml), and amphoterecin B (0.125 μg/ml). The cells were incubated at 37°C in humidified 5% CO2 in air. Experiments were conducted on passages 2 and 3 cells in medium that was devoid of growth supplements.
Morphological, biochemical, and immunohistochemical tests (4, 9) confirmed the cells to be of proximal tubular origin. The cells grow in monolayer in culture and have typical cobble stone appearance. Scanning and transmission electron microscopy revealed that the PTEC have polarized morphology with numerous apical microvilli and tight junctions. The cells expressed the brush-border enzymes alkaline phosphatase activity and -glutamyl transferase, were immunopositive for cytokeratin, displayed glucose-dependent glucose uptake, and exhibited cAMP stimulation by parathyroid hormone but not by arginine vasopressin.
Culture of HK-2 cells. HK-2 cells were cultured in DMEM/F-12 (17 mM glucose) supplemented with 10% FBS, penicillin (50 U/ml), streptomycin (50 μg/ml), and amphoterecin B (0.125 μg/ml). Experiments were conducted in FBS-free medium.
Preparation of glucose media. Unlike in vivo, both PTEC and HK-2 cells require and are routinely cultured in glucose-enriched media (usually 17 mM). Because this is actually "hyperglycemia" in vivo, the choice of ambient glucose concentration in the culture medium that can be considered the "control" becomes critically important. To address this issue, two sets of experiments were designed. In the first set, 17 mM glucose (the medium in which PTEC were isolated, cultured, and characterized) was designated the control and, in the second set, a medium constituted with 5 mM glucose (as cited in most of the literature) served as the control.
To prepare culture media containing a range of glucose concentrations, several combinations of culture media were considered. If required, glucose concentrations were augmented by the addition of D-glucose (Sigma): medium A: DMEM/F-12 containing 17 mM glucose (GIBCO cat. no. 11330032; the medium used for the isolation, culture, and characterization of PTEC); medium B: DMEM/F-12 with 47 mM glucose, prepared by adding glucose to medium A; medium C: DMEM without glucose (GIBCO cat. no. 1196025); medium D: F-12 with 10 mM glucose (GIBCO cat. no. 11765054); medium E: DMEM/F-12 with 5 mM glucose, prepared by mixing equal volumes of medium C and medium D; medium F: DMEM/F-12 with 30 mM glucose (medium E with additional glucose); medium G: DMEM with 5 mM glucose (medium C with additional glucose); and medium H: DMEM with 30 mM glucose (medium C with additional glucose).
Because the media combinations G and H do not contain F12, the effect of the presence (or absence) of F-12 on cell growth and death parameters was investigated in our pilot studies. A comparison was made between cells grown in DMEM/F-12 with 5 or 30 mM glucose (media E and F, respectively) and cells grown in DMEM at the same glucose concentrations but without F-12 (media G and H, respectively). As the results showed no significant differences between the two groups, the second set of experiments that considered 5 mM glucose as the control was carried out using the latter (DMEM without F-12).
In the cell culture experiments described below, the effect of media containing 47 mM glucose (medium B) was compared with 17 mM glucose (first control, i.e., medium A), and 30 mM (medium H) was compared with 5 mM glucose (second control, i.e., medium G).
Experimental protocol for primary cultures of PTEC. PTEC (5 x 104 cells/ml) were cultured in serum-free DMEM/F-12 supplemented with growth factors in 24-well culture plates. Only cells from passages 2 and 3 were used for experiments. Subconfluent cells were washed and incubated in growth supplement-free medium (medium A) for 24 h. After 24 h, the cells were incubated in medium A (17 mM control) and medium B (47 mM high glucose) and comparisons were made between these two groups. In a parallel second set of experiments, PTEC were exposed to medium G (5 mM control) and medium H (30 mM high glucose) and a comparison was made between these two groups. The experiments were carried out for 24 h, 48 h, 72 h, and 6 days. The volume of culture medium in each well was 1 ml. Mannitol was used as osmotic control. Positive controls were chosen on the basis of their known efficacy with respect to the parameter under investigation.
Experimental protocol for HK-2 cells. HK-2 cells (1 x 105 cells/ml) were cultured in 24-well plates in DMEM/F-12 (17 mM glucose) supplemented with 10% FBS. Subconfluent cells were exposed to FBS-free culture media containing various concentrations of glucose and comparisons made as described above. The experiments were carried out for 24 and 48 h.
Apoptosis and necrosis measurement by flow cytometry. Apoptosis and necrosis were determined using a commercially available kit (Annexin-V-FLUOS Staining Kit, Roche Diagnostics). In brief, after the appropriate treatment periods, nonadherent cells were pelleted and added to trypsinized and pelleted adherent cells. The cells were resuspended in 100 μl of binding buffer containing fluorescein isothiocyanate (FITC)-conjugated annexin-V and propidium iodide (PI) and incubated at room temperature for 15 min. After the incubation period, 300 μl of binding buffer were added and the cells were analyzed in a FACS Calibur (Beckton Dickinson) using 488-nm excitation and a 515-nm band pass filter for fluorescein detection and a filter >600 nm for PI detection. Ten thousand events were recorded from each treatment group.
Apoptosis measurement using in situ end labeling. Apoptosis was also determined using a commercially available ApopTag Peroxidase kit (Serologicals) that is based on the TUNEL (TdT-mediated nick end labeling) method. Briefly, PTEC were grown on Thermanox coverslips (Nalge Nunc International) in 24-well plates. After the appropriate treatment periods, cells were washed in PBS and fixed in 1% paraformaldehyde for 10 min at room temperature. The fixative was washed away and the cells were postfixed in precooled ethanol: acetic acid mixture (2:1 vol/vol) for 3 min at 20°C. After the endogenous peroxidase with 3.0% hydrogen peroxide in TBS was quenched, the cells were labeled with the reaction buffer containing TdT-digoxigenin-nucleotide and allowed to bind with peroxidase-conjugated antidigoxigenin. The color was developed with DAB and counterstained with hematoxylin, dehydrated in ethanol, cleared in xylene, and mounted. The cells were viewed under a x40 objective lens and the cells that fell within the 100 squares of an eye graticule were counted. Apoptotic nuclei showed one or more of the following changes: condensation, hyperchromasia, crescent shape, and apoptotic bodies. Apoptotic cells was expressed as a percentage of the total cells counted.
Cell proliferation assay using 5-bromo-2'-deoxyuridine. Cell proliferation was determined using a commercially available kit (Cell Proliferation ELISA, BrdU Colorimetric kit, Roche Diagnostics). Cells grown in 96-well culture plates were incubated in 100 μl of respective experimental glucose media. Ninety minutes before the selected treatment periods, 10 μl of 5-bromo-2'-deoxyuridine (BrdU) labeling solution were added to each well and incubated at 37°C. The BrdU labeling solution was removed and 200 μl of FixDenat were added to each well and incubated for 15 min at room temperature. After the FixDenat solution was removed, 100 μl of anti-BrdU-POD working solution were added to each well and incubated for 60 min at room temperature. The secondary antibody conjugate was removed and the cells were rinsed three times with the washing solution. Substrate solution was added (100 μl), incubated at room temperature for 20 min, and the color was measured in a microplate reader at 370 nm with a reference wavelength of 492 nm.
Metabolic assay using MTT. Metabolic activity was measured using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT). In brief, cells were grown in 96-well culture plates in 100 μl of the respective experimental glucose media. Ninety minutes before the selected treatment periods, 10 μl of MTT solution (5 mg/ml in PBS) were added to each culture and incubated at 37°C. The culture medium was removed and the purple crystals formed were dissolved in 150 μl of 0.1 N HCl in isopropanol. The absorbance was measured at 570 nm with a background correction of 690 nm.
Protein assay. Cells were grown in 96-well plates for selected time periods. The culture medium was removed and cells were washed twice with PBS. The cells were lysed in 50 μl of RIPA buffer (0.5% sodium deoxycholate, 0.1% SDS, and 1% nonidet P-40 in PBS) at 4°C. BCA protein assay reagent mix (Pierce) was added (150 μl) and the color was developed for 20 min at room temperature and read in a microplate reader at 562 nm. Bovine serum albumin dissolved in RIPA buffer was used as standard.
Glucose concentrations in the culture medium. PTEC and HK-2 cells were exposed to DMEM containing 5, 17, 30, and 47 mM glucose. The culture media were prepared by adding appropriate concentrations of glucose to DMEM without glucose (medium C). The glucose concentration in the medium was measured every 24 h until the end of the study using the Roche/Hitachi Modular system (Roche, Mannheim, Germany). To find out whether glucose undergoes degradation during the course of the experiment, these culture media were also incubated in 24-well plates without cells. The glucose concentrations were measured every 24 h as above.
Glucose replenishment experiments. PTEC and HK-2 cells were exposed to 5, 17, 30, and 47 mM glucose in 96-well plates. In one set of experiments, the culture media in all four treatment groups were replenished every 24 h and in the other set, the culture media were not replenished until the end of the study. Cell proliferation, metabolic activity, and protein content in PTEC and HK-2 cells were measured at 6 days and 48 h, respectively. Lactate dehydrogenase (LDH) release (a measure of necrosis) was measured using the Roche/Hitachi Modular system (Roche).
Statistical analysis. Experiments involving PTEC were carried out three times in duplicate, using cells obtained from three different nephrectomy samples. Experiments with HK-2 cells were carried out six times. The results were expressed as means ± SE. Comparisons among groups were performed using one-way ANOVA with Tukey's post hoc analysis. Analyses were performed using Graphpad InStat software (San Diego, CA). P < 0.05 was considered significant. Significant changes in the parameters, if present, were observed only on day 6 for PTEC and at 48 h for HK-2 cells. Therefore, the results obtained at 48 and 72 h for PTEC are not included.
RESULTS
Apoptosis. Exposure of PTEC or HK-2 cells to various concentrations of glucose did not result in any significant differences in apoptosis as measured by annexin binding (Fig. 1, A and B). The TUNEL method in combination with morphological verification also failed to show any significant changes in apoptosis in response to high glucose compared with low glucose (Fig. 2, A and B).
Necrosis. No significant changes in necrosis in response to high experimental glucose concentrations (47 compared with 17 mM) were observed in PTEC or in HK-2 cells during the study (Fig. 3, A and B). However, on day 6, PTEC exposed to low glucose (5 mM) showed a significant increase in necrosis compared with the groups treated with high glucose (30 mM; Fig. 3A).
Cell proliferation and metabolic activity. High ambient glucose failed to induce any significant differences in cell proliferation (Fig. 4, A and B) and metabolic activity (Fig. 5, A and B) in both PTEC and HK-2 cells throughout the study period. However, on day 6 in PTEC and at 48 h in HK-2 cells, low glucose (5 mM) induced a significant reduction in cell proliferation (Fig. 4, A and B) and metabolic activity (Fig. 5, A and B) compared with the 30 mM glucose group.
Protein content. PTEC exposed to 5 mM glucose showed a significant reduction in protein content on day 6 without any changes at other time points (Fig. 6A) compared with 30 mM groups (Fig. 6A). Exposure of HK-2 cells to various concentrations of glucose failed to induce any significant differences in protein content (Fig. 6B).
Glucose concentrations in the medium. Measurement of glucose concentrations of the culture medium in which the cells were grown showed a linear decline with time in the four groups (Fig. 7, A and B). By 48 h, the glucose concentration in the culture medium containing 5 mM glucose had fallen to 1.2 ± 0.4 mM for PTEC (1.23 ± 0.03 for HK-2 cells) and by 72 h the glucose concentration was less than 0.3 mM. Such a decrease in glucose concentration was not observed in the culture media that were incubated without cells (Fig. 7C).
Replenishment of glucose. Measurement of cell proliferation, metabolic activity, protein content, and LDH release was carried out on day 6 for PTEC and at 48 h for HK-2 cells. These time points were chosen because significant changes in these parameters were previously observed at these time points (Figs. 4 to 6). When the culture media were replenished every day, no significant differences in cell proliferation (Fig. 8), metabolic activity (Fig. 9), and protein content (Fig. 10) between the low (5 mM)- and high-glucose groups (17, 30, and 47 mM) were observed. When the media were not replenished, cells in the 5-mM group showed significant reproducible changes in these growth parameters (Figs. 810), similar to those observed previously (Figs. 46). Thus, when the medium was not replenished, PTEC showed a decrease in cell proliferation, metabolic activity, and protein content when compared with respective glucose groups in which the medium was replenished. The role of low glucose (5 mM) in inducing significant necrosis (as measured by propidium iodide uptake; Fig. 3A) was confirmed by the observation of increased LDH release when PTEC were cultured in nonreplenished media containing 5 mM of glucose (Fig. 11).
DISCUSSION
The selection of the control group is very important when studying the role of hyperglycemia in the behavior of PTEC in vitro. Control conditions in many published studies have been defined as between 5 and 6.1 mM glucose to reflect the in vivo concentrations of human plasma (3 to 7.8 mM). However, these normoglycemic concentrations of glucose are not optimal for human PTEC in vitro, which are routinely isolated and cultured in media with higher glucose concentrations (4, 10, 11). For example, DMEM/F12 medium is usually constituted with 17 mM glucose. An ideal model would require these cells to be isolated and grown under normoglycemic conditions (5 mM glucose or within the normal range of 3.0 to 7.8 mM). But this is not done routinely nor has it been a feature of earlier publications. It is doubtful whether these cells can be isolated from nephrectomy samples, cultured, and characterized in such low-glucose concentrations, and our attempts to isolate human PTEC in 5 mM glucose from nephrectomy samples were unsuccessful. Furthermore, HK-2 cells are successfully grown in 17 mM glucose (DMEM/F-12 or DMEM alone supplemented with 10% FBS). In our laboratory, these cells show excessive vacuolations and altered morphology (which are markers of cell stress) when grown in 5 mM glucose. This substantiates what is well known, namely, that primary cultures of human PTEC and HK-2 cells (and most cell types) require higher "diabetic" concentrations of glucose for "normal" cell survival and growth in vitro. The question therefore arises as to what controls should be used in in vitro models of DN using PTEC and HK-2 cells. To address this question, we considered 5 and 17 mM glucose concentrations as controls and compared subsequent cell turnover with media containing higher glucose concentrations.
We found that high ambient glucose concentrations were effect neutral and induced neither apoptosis nor necrosis of PTEC or HK-2 cells. This contrasts with previous in vivo (8) and in vitro (1, 15, 27, 28) studies that attributed a direct role for high glucose in inducing apoptosis of PTEC. For example, Ishii et al. (8) found that intravenous loading of rats with extremely high concentration of glucose (550 mM or 10% glucose solution) for 5 h produced a significant increase in DNA fragmentation and the ladder-like pattern characteristic of apoptosis in rat proximal tubular cells. With respect to in vitro studies, exposure of mouse PTEC to 25 mM glucose induced a significant increase in apoptosis as early as 24 h (15). This was associated with an increased expression of the proapoptotic Bax gene and a decreased expression of the anti-apoptotic Bcl-2 gene (15). LLC-PK1 cells (porcine proximal tubular epithelial cell line) exposed to 25 mM glucose (1) and HK-2 cells treated with 30 mM glucose (27, 28) have been reported to undergo apoptotic cell death at 48 h. We were unable to find any significant changes in apoptosis of primary cultures of human PTEC and HK-2 cells in response to a range of glucose concentrations.
To our knowledge, there are no previous reports on the role of high glucose on apoptosis of human PTEC in primary culture. We have no explanation as to why we did not observe apoptosis in HK-2 cells in response to high glucose as reported by others (27, 28), despite the use of similar methods. Methodological error can be ruled out because the positive controls in our studies produced significant apoptosis in both cell types. However, there are emerging reports that suggest that high glucose enhances survival rate in pancreatic -cells as well as neurons (20, 23), that high glucose inhibits apoptosis and necrosis of neural, gastric, and cardiac cells (57, 19, 21), and that high glucose protects cardiac cells against hypoxic insults (12, 17). Interestingly, high ambient glucose did not induce necrosis in any of the treatment groups in the present study, but we did observe a significant increase in necrosis of human PTEC exposed to low glucose on day 6.
The role of high glucose in hyperplasia and hypertrophy of PTEC is also controversial. Mouse (30) and rabbit (16) PTEC showed a significant reduction in cell proliferation and increase in protein content, suggesting that hypertrophy is the predominant response to high ambient glucose. Studies of human PTEC exposed to 25 mM glucose for 6 days have reported that the cells undergo significant proliferation without much change in protein content (10, 11). These studies concluded that hyperplasia, not hypertrophy, is the major response to high glucose (10, 11). Although we observed no changes in cell growth characteristics in the high-glucose groups, human PTEC exposed to 5 mM glucose for 6 days showed a decrease in cell proliferation, metabolic activity, and protein content. There was a similar decrease in proliferation and metabolic activity of HK-2 cells at 48 h but the protein content was unchanged.
To determine whether the observed changes in cell proliferation, metabolic activity, and protein content were due to an increase in response to high glucose as reported in the literature (10, 11) or a decrease in response to low glucose, further experiments were carried out using human PTEC and HK-2 cells. Analysis of glucose concentrations in the media in which the cells were grown showed a steady decrease in glucose concentration during the course of the experiments, reaching undetectable levels in the 5-mM glucose group (Fig. 7). This decrease was not due to the degradation of glucose in the culture medium, but solely due to utilization by the cells. These findings support our hypothesis that the reduced cell growth and increased cell death observed in the low-glucose medium (5 mM) were the consequence of glucose depletion such that cell survival was compromised rather than high glucose inducing hyperplasia and/or hypertrophy.
To verify this conclusion, we examined the effects of replenishing the culture media constituted with the experimental glucose concentrations every day. Interestingly, when the culture media were replenished, no significant differences in any of the indexes of cell death (LDH release) or growth (proliferation, metabolic activity, and protein content) were observed between high- and low-glucose groups. Less cell proliferation, lower metabolic activity, and protein content were again observed in the nonreplenished low-glucose group (5 mM) compared with the nonreplenished high-glucose groups. The significant increase in LDH release together with necrosis in the nonreplenished low-glucose group clearly shows that low glucose rather than high glucose is responsible for the observed changes.
In summary, this study does not support the notion that high glucose induces either cell growth or cell death in primary cultures of human PTEC or HK-2 cells, at least under the experimental conditions we employed. Irrespective of the glucose concentration in the medium in which these cells are routinely grown, it is imperative to interpret the results of in vitro models of DN in the context of changes in glucose concentrations during the course of the experiment. Ignoring the longitudinal changes in glucose concentration during an experiment could lead to the misinterpretation that high glucose induces growth of PTEC. The current knowledge of the pathophysiology of high glucose based on cell culture systems may need to be reevaluated.
GRANTS
Part of this work was presented in abstract form at the 40th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide, Australia, September 2004. This study was supported in part by the Queensland Health Pathology and Scientific Service and the Royal Brisbane and Women's Hospital Research Foundation, Brisbane, Australia.
ACKNOWLEDGMENTS
The authors thank the surgeons for access to the patients, and the patients for permission to use excess nephrectomy tissue in the present studies.
FOOTNOTES
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
REFERENCES
Allen DA, Harwood S, Varagunam M, Raftery MJ, and Yaqoob MM. High glucose induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 17: 908910, 2003.
Bader R, Bader E, Grung KE, Markensen-Haen S, Christ H, and Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 167: 204216, 1980.
Gilbert RE and Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury Kidney Int 56: 16271637, 1999.
Glynne PA. Primary culture of human proximal renal tubular epithelial cells. In: Methods in Molecular Medicine, vol 36: Septic Shock, edited by Evans TJ. Totowa, NJ: Humana Press, 1999, p. 197205.
Hall JL, Matter CM, Wang X, and Gibbons GH. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ Res 87: 574580, 2000.
Honda K, Kato K, Dairaku N, Iijima K, Koike T, Imatani A, Sekine H, Ohara S, Matsui H, and Shimosegawa T. High levels of intracellular ATP prevent nitric oxide-induced apoptosis in rat gastric mucosal cells. Int J Exp Pathol 84: 281288, 2003.
Honma H, Podratz JL, and Windebank AJ. Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy. J Peripher Nerv Syst 8: 6574, 2003.
Ishii N, Ogawa Z, Suzuki K, Numakami K, Saruta T, and Itoh H. Glucose loading induces DNA fragmentation in rat proximal tubular cells. Metabolism 45: 13481353, 1996.
Johnson DW, Brew BK, Poronnik P, Cook DI, Gyory AZ, Field MJ, and Pollock CA. Transport characteristics of human proximal tubule cells in primary culture. Nephrology 3: 183194, 1997.
Jones SC, Saunders HC, Qi W, and Pollock CA. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 42: 11131119, 1999.
Jones SC, Saunders HJ, and Pollock CA. High glucose increases cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabet Med 16: 932938, 1999.
Kim MH, Yung YS, Moon CH, Jeong EM, Lee SH, Baik EJ, and Moon CK. Isoform-specific induction of PKC-epsilon by high glucose protects heart-derived H9c2 cells against hypoxic injury. Biochem Biophys Res Commun 309: 16, 2003.
Mason RM and Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 13581373, 2003.
Morais C, Westhuyzen J, Metharom P, and Healy H. High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells. Nephrol Dial Transplant 20: 5058, 2005.
Oritz A, Ziyadeh FN, and Nielson EG. Expression of apoptosis regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and diabetic kidneys. J Investig Med 45: 5056, 1997.
Park SH, Choi HJ, Lee JH, Woo CH, Kim JH, and Han HJ. High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress and TGF-1. Kidney Int 59: 16951705, 2001.
Ramasamy R, Hwang YC, Whang J, and Bergmann SR. Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4. Am J Physiol Heart Circ Physiol 281: H290H297, 2001.
Ritz E, Rychilik I, Locatelli F, and Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimension. Am J Kidney Dis 34: 795808, 1999.
Sakuma H, Yamamoto M, Okumura M, Kojima T, Maruyama T, and Yasuda K. High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1. Am J Physiol Cell Physiol 283: C422C428, 2002.
Sango K, Horie H, Saito H, Ajiki K, Tokashiki A, Takeshita K, Ishigatsubo Y, Kawano H, and Ishikawa Y. Diabetes is not a potent inducer of neuronal cell death in mouse sensory ganglia, but it enhances neurite regeneration in vitro. Life Sci 71: 23512368, 2002.
Schaffer SW, Croft CB, and Solodushko V. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 278: H1948H1954, 2000.
Seyer-Hansen K, Hansen J, and Gunderson HJG. Renal hypertrophy in experimental diabetes. Diabetologia 18: 501505, 1980.
Srinivasan S, Bernal-Mizrachi E, Ohsugi M, and Permutt MA. Glucose promotes pancreatic beta cell survival through a PI 3-kinase/Akt-signalling pathway. Am J Physiol Endocrinol Metab 283: E784E793, 2002.
Taft J, Nolan CJ, Yeung SP, Hewston TD, and Martin FIR. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43: 10461051, 1994.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977986, 1993.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837853, 1998.
Verzola D, Bertolotto MB, Villagio B, Ottonello L, Dallegri F, Frumento G, Berruti V, Gandolfo MT, Garibotto G, and Deferrari G. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 50: 443451, 2002.
Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Salvatore F, Berruti V, Gandolfo MT, Garibotto G, and Deferrari G. Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells. J Am Soc Nephrol 15, Suppl 1: S85S87, 2004.
Ziyadeh F. Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int 49, Suppl 54: S10S13, 1996.
Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, and Haverty TP. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 259: F704F714, 1990.